These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36454409)

  • 1. The blood-to-plasma ratio and predicted GABA
    Manchester KR; Waters L; Haider S; Maskell PD
    Forensic Toxicol; 2022 Jul; 40(2):349-356. PubMed ID: 36454409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental versus theoretical log D
    Manchester KR; Maskell PD; Waters L
    Drug Test Anal; 2018 Mar; ():. PubMed ID: 29582576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designer benzodiazepines' pharmacological effects and potencies: How to find the information.
    El Balkhi S; Monchaud C; Herault F; Géniaux H; Saint-Marcoux F
    J Psychopharmacol; 2020 Sep; 34(9):1021-1029. PubMed ID: 31971477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of prescribed and designer benzodiazepines and metabolites in influent wastewater.
    Bade R; Ghetia M; White JM; Gerber C
    Anal Methods; 2020 Jul; 12(28):3637-3644. PubMed ID: 32701083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designer Benzodiazepines: A Review of Toxicology and Public Health Risks.
    Brunetti P; Giorgetti R; Tagliabracci A; Huestis MA; Busardò FP
    Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34208284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
    Pettersson Bergstrand M; Helander A; Hansson T; Beck O
    Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a quantitative structure-activity relationship (QSAR) model to predict GABA-A receptor binding of newly emerging benzodiazepines.
    Waters L; Manchester KR; Maskell PD; Haegeman C; Haider S
    Sci Justice; 2018 May; 58(3):219-225. PubMed ID: 29685303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project.
    Bäckberg M; Pettersson Bergstrand M; Beck O; Helander A
    Clin Toxicol (Phila); 2019 Mar; 57(3):203-212. PubMed ID: 30348014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designer Benzodiazepines: Another Class of New Psychoactive Substances.
    Moosmann B; Auwärter V
    Handb Exp Pharmacol; 2018; 252():383-410. PubMed ID: 30367253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an LC-MS/MS Method for the Quantification of 13 Designer Benzodiazepines in Blood.
    Mei V; Concheiro M; Pardi J; Cooper G
    J Anal Toxicol; 2019 Oct; 43(9):688-695. PubMed ID: 31436813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood concentrations of new designer benzodiazepines in forensic cases.
    Høiseth G; Tuv SS; Karinen R
    Forensic Sci Int; 2016 Nov; 268():35-38. PubMed ID: 27685473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent findings and advancements in the detection of designer benzodiazepines: a brief review.
    Wu D; Fu L
    Arh Hig Rada Toksikol; 2022; 74(4):224-231. PubMed ID: 38146763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of QSAR model based on Monte Carlo optimization for predicting GABAA receptor binding of newly emerging benzodiazepines.
    Antović A; Karadžić R; Živković J; Veselinovic A
    Acta Chim Slov; 2023 Nov; 70(4):634-641. PubMed ID: 38124634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast and Sensitive Method for the Determination of 17 Designer Benzodiazepines in Hair by Liquid Chromatography-Tandem Mass Spectrometry.
    DeFreitas L; Fonseca Pego AM; Kronstrand R; Lendoiro E; de Castro-Ríos A; Concheiro M
    J Anal Toxicol; 2022 Oct; 46(8):852-859. PubMed ID: 35748814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens.
    Garland JM; Hull JD; Bender CL; Marshall L; Holt AC
    J Addict Med; 2022 May-Jun 01; 16(3):354-356. PubMed ID: 34172626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017.
    Carpenter JE; Murray BP; Dunkley C; Kazzi ZN; Gittinger MH
    Clin Toxicol (Phila); 2019 Apr; 57(4):282-286. PubMed ID: 30430874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELISA Detection of Phenazepam, Etizolam, Pyrazolam, Flubromazepam, Diclazepam and Delorazepam in Blood Using Immunalysis® Benzodiazepine Kit.
    O'Connor LC; Torrance HJ; McKeown DA
    J Anal Toxicol; 2016 Mar; 40(2):159-61. PubMed ID: 26518230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designer benzodiazepines: an update.
    Yu X; Greenblatt HK; Greenblatt DJ
    Expert Rev Clin Pharmacol; 2023 Feb; 16(2):109-117. PubMed ID: 36649662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of designer benzodiazepines in human serum using non-aqueous capillary electrophoresis - Tandem mass spectrometry with successive multiple ionic - Polymer layer coated capillary.
    Švidrnoch M; Boráňová B; Tomková J; Ondra P; Maier V
    Talanta; 2018 Jan; 176():69-76. PubMed ID: 28917807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of selected designer benzodiazepines by ultra high performance liquid chromatography with high-resolution time-of-flight mass spectrometry and the estimation of their partition coefficients by micellar electrokinetic chromatography.
    Tomková J; Švidrnoch M; Maier V; Ondra P
    J Sep Sci; 2017 May; 40(9):2037-2044. PubMed ID: 28266783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.